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The goal of this research was to survey the literature of studies on
mesothelioma treatments and compare their rates of success. The
focus was on radiation therapy which is used with chemotherapy or
surgery treatment for this specific type of cancer. The research is
based on the chosen treatments of thirteen patients who shared their
stories on different websites (Table 1). The number of survived years
for these patients was compared. The results show that the average
number of years survived in patients who used mind-body therapy is
greater than other patients who use radiation therapy as palliation
with chemotherapy, surgery treatment or immune therapy as
treatment of their disease. The significance of this research was to
find the best treatment for mesothelioma cancer and find the
advantage of using radiation therapy as treatment in this specific type
of cancer. This was done by comparing the rate of patients who
survived longer with the survey in 1990 (Ball & Cruickshank, 1990).
Introduction
The definition of cancer is a disease in which abnormally
developed cells start to divide out of control. Cancer usually is named
after the type of cell or the organ in which they begin. There is a line
of cells contained in the abdomen (peritoneum), chest (pleura) and in
space around heart called the mesothelium. These cells protect organs
by secreting a special fluid that allows the organs to move. For
example, this fluid makes it easier for heart to pump outward.
Malignant mesothelioma has been categorized based on the position
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of the migrant cells: pleural mesotheliomas, which start in the chest,
peritoneal mesotheliomas which start in the abdomen, and pericardial
mesotheliomas which start in the outer layer around heart.
Additionally, mesothelioma is named based on the shape of the cancer
when viewed under a microscope. An epithelioid sarcoma is a rare
mesenchymal soft tissue tumor with an epithelioid pattern (FanburgSmith, Fetsch, Miettinen, Shmookler & Virolainen, 1999). And
sarcomatoid carcinoma is a relatively uncommon form of cancer
whose malignant cells have histological, cytological, or molecular
properties of both epithelial tumors (carcinoma) and mesenchymal
tumors.
Thousands of workers and servicemen have become disabled or
died because of the health effects of asbestos. The expectation is that
many more will be affected in near future (Craighead & Gibbs, 2008).
Asbestos fibers are a risk factor of mesothelioma, as they can travel to
the ends of the small airways and reach the cell lining of the lungs
during normal breathing. Asbestos fibers are naturally occurring
minerals. They are resistant to heat and corrosion. They are used in
products such as insulation for pipes (steam line), floor tiles, building
materials, and in vehicle brakes and clutches (Craighead & Gibbs,
2008).
What is yet to be understood is why mesothelioma is found in
children as well. Although the average age of diagnosis of
mesothelioma is sixty-five years, and is usually found in men, it has
been found in children as well. The risk factor for mesothelioma in
children has not been identified definitively. Children may also
experience direct exposure to asbestos in the home. This may occur
where there are damaged or worn asbestos fibers that have been
released into the air from old insulation or other old building
materials. In this situation, the child might inhale the fibers, which
would then become lodged in the chest or abdominal area, eventually
leading to the formation of mesothelioma cancer. Children can also
suffer secondary exposure. This can occur when someone else in their
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household works with asbestos – which is rare these days – and brings
home toxic dust on their clothes or in their hair. The child can breathe
in these fibers and may eventually get sick because of the exposure to
the hazardous substance (American Cancer Society, 2013).
Diagnosis
Normally, the cancer is diagnosed by an expert who looks at
samples of cancer, which could be cell or tissue, under microscope. In
some cases, lab tests of the cell proteins, DNA, and RNA can be used
for diagnosis as well. There are three ways to diagnose mesothelioma
cancer.
Screening such as X-ray, Fluroroscopy, CT
The standard way of diagnosis is through imaging. X-rays for
diagnostic procedures or research are produced by accelerating
electrons using a high voltage and allowing them to collide with a
metal target (Maniwa, Nishimura, Ohno, Takata & Yoshimura, 2008).
X-rays are produced when the electrons suddenly decelerate upon
collision with the metal target. These X-rays are products of what is
commonly called braking radiation. If the bombarding electrons have
sufficient energy, they can knock an electron out of an inner shell of
the target metal atoms. When a metal target is bombarded by highenergy electrons, X-rays are emitted. An X-ray spectrum typically
consists of a broad continuous spectrum and a series of sharp lines.
Where lines are depends on the metal is used. These X-rays are called
characteristic X-rays.
There are different imaging modalities: radiography, fluoroscopy,
computed tomography, nuclear medicine, magnetic resonance
imaging, and ultrasound.
In radiography, standard X-ray is used. The radiation will ionize
and it is the initial screening study of bone, chest, and abdomen for
mammography. In radiography, air (black), fat (dark gray),
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water/tissue (gray), bone (light gray), metal (white) appear in different
colors.
In fluoroscopy, the real-time X-ray uses ionizing radiation. It is
utilized for X-ray guided procedures, such as GL studies,
angio/interventional. Radiography shows the same tissues in the same
color.
In computed axial tomography, ionizing radiation is used and the
computer reconstructs cross-sectional (axial) images. It is the initial
screening for brain pathology and also for the chest, abdomen and
pelvis.
MESOMARK
The MESOMARK assay is one of the most promising diagnostic
markers for mesothelioma cancer (Alexander, 2006; Hino & Maeda,
2006 & Hino & Shiomi, 2007).
In a blood test called the MESOMARK assay, the levels of
soluble mesthelin-related peptide (SMRP) is measured. SMRP is a
protein released into the blood by cancerous mesothelioma cells.
Cancer progresses through a staging system which corresponds to
the severity of the cancer. This is based on the size and extent of the
primary tumor and whether or not cancer has spread in the body.
These stages help the medical doctors to plan appropriate treatment. It
can be used to deduce a patient’s cancer prognosis. It could also help
provide a platform for the exchange and comparison of information
between patients (Ebara et al, 2012). There are different ways to
determine the stage. Physical exams, imaging studies, laboratory tests,
pathology and surgical reports are the ways to track the stages of
cancer. The most widely used cancer staging system is TNM. It is
based on the size and reach of the primary tumor (T), the amount of
spread to lymph node (N), and the existence of metastasis (M). Five
stages are explained in the TNM systems. Usually mesothelioma is
diagnosed in stage three and four with symptoms. Pleural
mesothelioma symptoms are characterized by pain in the lower back
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or at the side of the chest, shortness of breath, cough, fever, sweating,
tiredness, weight loss, hoarseness, swelling of the face and arms.
Treatment
There are different treatments for surviving patients with
mesothelioma. These include the most used ones, which are radiation
therapy, surgery, targeted therapy, immune therapy, and
chemotherapy. In the mesothelioma, radiation therapy is used as a less
painful alternative. Radioactive particles are used in different ways
for treatment of this cancer. These are: radiation therapy,
chemotherapy, and immunotherapy (for high dose chemotherapy).
Surgery
Surgery is another option for a person who diagnosed with
mesothelioma. There are different types of surgery. Curative surgeries
are used in the early stage of mesothelioma, such as pneumonectomy,
extra pleural and pleurectomy. Palliative surgeries are another type of
surgery which is used to relieve mesothelioma symptoms like pain
and other problems associated with mesothelioma disease, such as
pleurocentesis, paracentesis, and pleurodesis.
Targeted Therapy or Molecularly Targeted Therapy
Molecularly targeted therapy is another option of treatment that
uses drugs or other substances to identify and attack specific cancer
cells (National Cancer Institute). This type of therapy has fewer side
effects than other types.
Chemotherapy
Chemotherapy is a type of treatment in which the cancer cells are
killed. This type of treatment could be useful depending on the stage
of cancer and where a patient is in treatment process. It could be used
for curing the cancer, preventing it from spreading, slowing its
growth, killing cancer cells that may have spread to other parts of
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body, and relieve the symptoms caused by cancer (American Cancer
Society.). Many clinical trials have tested the numerous
chemotherapeutic agents. The response rate doesn’t exceed more
than 20% for most of the investigated regimens (Maniwa, Nishimura,
Ohno, Takata, & Yoshimura, 2008).
Immune Therapy
Immune therapy is a type of injection chemotherapy which is
used for high-dose chemotherapy. In this type of treatment, the body’s
immune system is used to aid the fight against the cancer. Common
types of immunotherapy include monoclonal antibodies, cancer
vaccines, and non-specific immunotherapies. In immunotherapy,
radioactive materials are placed directly into the chest or the abdomen
at the site of the cancer. The radiation will move only a very short
distance, which limits the possible damage to nearby healthy tissues.
This is the method that is normally used for mesothelioma.
Radiation Therapy
Radiation therapy is a treatment in which beams of high-energy
particles are directed at cancer cells to reduce the potency of
cancerous cells. There are different types of radiation therapy, but two
are specifically used in treating mesothelioma. One is called external
beam radiation therapy (EBRT). In this regimen, the beam source is
usually on the outside of the patient’s body. A machine is used to
produce this type of beam. Another type of radiation therapy is
brachytherapy, in which the radiation source is placed close to the
surface of the body or within a body cavity.
In External Beam Radiation Therapy (EBRT), the source of
radiation may be outside the body of the patient (external radiation
therapy) or it may be an isotope that has been implanted into
abnormal tissue or a body cavity. Modern radiation therapy primarily
uses high-energy X-rays or gamma rays with peak photon energies,
exceeding 1 mega electron volte. Brachytherapy’s radiation sources
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are either low energy photon sources (for LDR, or low dose rate
applications) or high energy photon sources (used for high dose rate
brachytherapy). Beta brachytherapy is used for intravascular
brachytherapy for prevention of restenosis and ophthalmic
applicators).
Radiation therapy usually is used in two different ways. First, it is
used to cure cancer. In this way the goal is to destroy tumors that have
not spread to other body parts and reducing the risk that cancer will
return after surgery or chemotherapy. Second, radiation therapy is
used to reduce symptoms. In this way, shrinking tumors will improve
quality of life. For example, in mesothelioma, the symptoms cause
shortness of breath. The pain can be alleviated, however, by reducing
the size of tumors. Radiation is a type of energy in motion. It can be
in form of fast moving particles of energy waves. There are many
types of radiation in everyday life such as TV, infrared, visible light,
UV, X-Rays.
Atoms are not stable. The excess energy contained in an unstable
atom is released in the form of a few basic particles and energetic
waves. Alpha particles are the heaviest particles and are produced
when the heaviest elements decay. Beta particles are much lighter
than alpha particles. Another high energy particle is the gamma ray. It
is an energetic photon, or light wave, in the same electromagnetic
family as light and X-rays, but is much more energetic and harmful.
Gamma rays are also capable of damaging living cells, as they slow
down by transferring energy to surrounding cell components.
The major difference between gamma rays and X-rays is that
gamma rays have more energy. For example, gamma rays have over a
trillion times more energy than typical radio waves. When gamma
rays and X-rays interact with the human body, ionization happens,
because those waves have sufficient energy to dislodge electrons. The
radiation imparts enough energy to an orbital electron in an atom for
the electron to free itself. One of the problems with ionization is that
freed electrons can cause damage to living cells or DNA. If the
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radiation dose is small, the body can repair itself but a high dose can
cause biological damage.
The way ionizing radiation is used to cure cancer is that it
minimizes the dose to the healthy tissue, while maximizing the dose
to cancerous tissue. These doses are delivered in small fractions. Such
doses take advantage of the fact that healthy tissues have better repair
mechanisms for radiation damage than cancer cells have. A normal,
self-repairing cell cycle consists of four phases: mitosis, which takes
one hour, synthesis, which takes six to fifteen hours (depending on
what kind of cell it is), G2, which takes 3 to 4 hours, and G1, which is
variable.
Treatment planning systems contain five steps which are
positioning, contouring, beam arrangement, optimization and dose
calculation and display.
The problem with radiation therapy for mesothelioma is that the
cancer is in close proximity to the heart and lungs and it is risky to
provide the kind of high-dose, intensive therapy needed to shrink the
tumor. IMRT (Intensity-Modulated Radiation Therapy) can more
accurately target cancer cells and avoid healthy tissue. It may provide
better results when performed by experienced clinicians.
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Table 1. Number of Years Patients Survived when Using Different
Treatments for Mesothelioma.
Survived
Type of Mesothelioma

Years

Type of Treatment

Peritoneal Mesothelioma

12

Immune Augmentative Therapy

Peritoneal Mesothelioma

6

Surgery and Radiation Therapy

Peritoneal Mesothelioma

21

Antioxidant (melatonin) Immune Therapy

Peritoneal Mesothelioma

4

Surgery and Radiation Therapy

Peritoneal Mesothelioma

5

Chemotherapy and Radiation Therapy

Peritoneal Mesothelioma

7

Strict Nutritional Regimen and Mind-Body Therapy

Peritoneal Mesothelioma

15

Strict Nutritional Regimen and Mind-Body Therapy

Peritoneal Mesothelioma

20

Peritoneal Mesothelioma

8

Mind-Body Therapy

Peritoneal Mesothelioma

5

Physical Therapy and Radiation Therapy

Peritoneal Mesothelioma

10

Surgery and Radiation Therapy

Pleural Mesothelioma

7

Surgery (EPP) and Radiation Therapy

Pleural Mesothelioma

20

Surgery and Radiation Therapy

Table 2. Stem Plot - Treatments vs. Years Survived.
Immune Therapy

Surgery

12
21
5

6
4
10
7
20

Mind-Body
Therapy
7
15
8

In the research presented above, three different treatments were
compared (Table 2). These were: immune therapy, surgery, and mindbody therapy. The averages of the years the patient survived past the
time the cancer is diagnosed was measured. Averages are shown in
the following graph.
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Figure 1. Different Treatments vs. Years Survived.

Figure 1 shows that the average number of years survived in
patients who used immune therapy is greater than the other patients
who used surgery and radiation therapy.
Conclusion
One of the rarest forms of cancer is mesothelioma. The cancer
cells are found in pleura or peritoneum (Carbone, Pass & Vogelzang,
2005). The fact about Mesothelioma is that by the time the symptoms
appear the disease is often advanced. Regardless of the type of
treatment, in an advanced situation it is difficult to treat it. According
to a survey in 1990, the median amount of time the patient survived
since the time of diagnosis, out of 38 patients, was 9 months, with an
estimated 2-year survival rate of 16%. Radiation therapy is more
useful for palliation (Ball & Cruickshank, 1990). This research
introduced mesothelioma cancer and then further explained the
different methods of diagnosis. The imaging methods in which
radiation particles are used were delineated. The different treatments
for mesothelioma were introduced. Patients who were treated with
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immune therapy, surgery, and mind body therapy were compared in
terms of the number of years survived. Also, the advantages and
practical aspects of radiation therapy were explained. In summary,
this research shows that patients who suffered from mesothelioma
cancer and chose the immune therapy treatment to treat it have
survived longer in comparison to patients who used other methods of
treatment.
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